Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

$1.6B

Market Cap • 11/18/2024

2017

(7 years)
Founded

2020

(4 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Princeton

Headquarters • New Jersey